The cancer industry is probably the most prosperous business in the United States. In 2014, there will be an estimated 1,665,540 new cancer cases diagnosed and 585,720 cancer deaths in the US. $6 billion of tax-payer funds are cycled through various federal agencies for cancer research, such as the National Cancer Institute (NCI). The NCI states that the medical costs of cancer care are $125 billion, with a projected 39 percent increase to $173 billion by 2020. The simple fact is that the cancer industry employs too many people and produces too much income to allow a cure to be found. All of the current research on cancer drugs is based on the premise that the cancer market will grow, not shrink. John Thomas explains to us why the current cancer industry prospers while treating cancer, but cannot afford to cure it.
Many things were different in 1995 than they are today. At that time, we did not have easy access to information about alternative cancer treatments. We did learn about a few alternatives and tried some of them, but the cancer kept growing. My wife refused to consider any alternative that would require her to make major lifestyle changes. She was willing to try therapies as long as she could keep working and could continue eating the standard American diabetic diet, which was a high-carbohydrate, low-fat diet. She only became willing to consider other alternative treatments when she was within a couple weeks of death. She lived for exactly one year from the time of her diagnosis.
No comments:
Post a Comment